Potent melanocortin receptor agonist and endogenous adrenocorticotropic hormone (ACTH) fragment
CAT No: R1830
CAS No:4037-01-8
Synonyms/Alias:ACTH (4-10);4037-01-8;Met-glu-his-phe-arg-trp-gly;4-10-Semax;corticotropin (4-10);Msh-acth (4-10);ACTH 4-10;H-Met-Glu-His-Phe-Arg-Trp-Gly-OH;N-(N-(N(2)-(N-(N-(N-L-Methionyl-L-alpha-glutamyl)-L-histidyl)-L-phenylalanyl)-L-arginyl)-L-tryptophyl)glycine;UNII-J48AU3I790;J48AU3I790;(4S)-4-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-(carboxymethylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid;GLYCINE, L-METHIONYL-L-.ALPHA.-GLUTAMYL-L-HISTIDYL-L-PHENYLALANYL-L-ARGINYL-L-TRYPTOPHYL-;corticotropin 4-10;ACTH-MSH (4-10);human ACTH (4-10);porcine ACTH (4-10);ACTH - msh (4-10);4-10-Corticotropin;ACTH4-10;CHEMBL2028951;DTXSID001031210;HY-P1478;(5S,8S,11S,14S,17S)-14-((1H-Imidazol-4-yl)methyl)-5-((1H-indol-3-yl)methyl)-17-((S)-2-amino-4-(methylthio)butanamido)-11-benzyl-8-(3-guanidinopropyl)-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaicosane-1,20-dioic acid;MS-31803;PD100148;CS-0044415;G12436;Q27281179;GLYCINE, L-METHIONYL-L-ALPHA-GLUTAMYL-L-HISTIDYL-L-PHENYLALANYL-L-ARGINYL-L-TRYPTOPHYL-;
Chemical Name:Adrenocorticotropic Hormone (ACTH) (4-10), human
1. The spatiotemporal control of signalling and trafficking of the GLP-1R
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.